Bills · S 5297
IN COMMITTEE· 119TH CONGRESS
Senate BillS 5297Health
American Pharmaceutical Security Act
The bill directs CMS to report on possible ways to protect pharmaceutical ingredient markets and reduce reliance on foreign adversaries.AI-written
INTRO AUG 6· LAST ACTION AUG 6
PASSAGE CHANCESLONG SHOT
2%
READING
2MIN
COSPONSORS
1
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
tl;dr
AI-writtenCMS would have to report to Congress on whether its coverage and payment tools could help protect pharmaceutical ingredient supplies. The bill requires a study, not new prices or purchasing rules.
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThe report could give Congress information about whether CMS coverage and payment tools might support domestic manufacturing or favor domestic sources when available. It would also have to identify missing information about ingredient origins and supplier ownership, which the administrator would need to carry out the recommendations.
KEY PROVISIONS
4AI-extractedPROVISION 01
Requires the CMS administrator to submit a report to Congress within one year after enactment.
The report is the bill's main required action.
PROVISION 02
The report must cover findings and policy recommendations on using CMS coverage and payment tools to protect U.S. and allied markets for pharmaceutical ingredients and reduce dependence on foreign adversaries.
It sets the subject and goals the report must address.
PROVISION 03
The report may recommend minimum-price commitments to support domestic manufacturing and protect it from nonmarket practices and price manipulation.
This identifies one possible way to support domestic suppliers, but does not itself establish minimum prices.
PROVISION 04
The report may recommend prioritizing domestically made ingredients when a domestic source exists, and must identify needed data gaps about origin and ownership.
These recommendations could inform future policy, while the required data review would identify information CMS lacks.
SPONSORSHIP
1 + 1
D· California
YRS IN OFFICE
25
BILLS LED
97
COSPONSOR BREAKDOWNBIPARTISAN · 0%
DEM 0 REP 1 IND 0
ACTION TIMELINE
2 EVENTSAUG 6
Introduced in Senate
AUG 6
Read twice and referred to the Committee on Finance.
BILL INFO
TypeSenate Bill
NumberS 5297
Congress119th
StatusIn Committee
IntroducedAug 6, 2026
Last actionAug 6, 2026
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · FINANCE COMMITTEE · INTRODUCED AUG 6, 2026
Senate BillS 5297Health
American Pharmaceutical Security Act
The bill directs CMS to report on possible ways to protect pharmaceutical ingredient markets and reduce reliance on foreign adversaries.AI-written
INTRODUCED AUG 6, 2026· LAST ACTION AUG 6, 2026
PASSAGE CHANCES
2%
READING
2 min
COSPONSORS
1
COMPLEXITY
Simple
